Loading...
01/11 04:05
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a 42% revenue increase and reduced operating losses, indicating improved financial performance. Despite management's lack of clear guidance for 2025, strong growth in product and service revenues, along with a significant sales backlog, suggests positive momentum. The Q&A section highlights increased interest in food safety applications and potential regulatory advancements, which could drive demand. While regulatory challenges and unclear guidance are concerns, the overall sentiment is positive due to strong financial results and growth prospects.
Total Revenue $1,577,000 for Q1 2025, up from $1,114,000 in Q1 2024, representing a 42% increase driven by heightened demand for BIT solution, mobile systems, SIS, and increased revenue from IHP corporate services.
Product-Based Revenue $1,000,000 in Q1 2025, reflecting a 35% growth compared to Q1 2024.
Service Revenue $577,000 in Q1 2025, a 56% increase from the same prior year period.
BIT Solution Sales Approximately $300,000 in Q1 2025, marking nearly a 200% increase from just over $100,000 in Q1 2024.
Technical Support Revenue Notable increase of 42% indicating that clients are utilizing equipment more frequently.
Gross Margin 60.4% for Q1 2025, compared to 60.2% in Q1 2024.
Operating Loss Approximately $754,000 in Q1 2025, an improvement from the operating loss of $1,226,000 in Q1 2024.
Net Loss Approximately $256,000 or $0.01 per share in Q1 2025, compared to $1,310,000 or 7% loss per share in the prior year.
Cash and Cash Equivalents Approximately $674,000 as of 03/31/2025.
Working Capital $3,800,000 as of 03/31/2025.
Shareholder Equity $3,800,000 as of 03/31/2025.
Accounts Payable Approximately $700,000, lower than $1,700,000 reported for Q1 2024.
Sales Backlog Increased from approximately $877,000 at the end of 2024 to $1,600,000 by the end of Q1 2025.
IHP Corporate Service Deployment Revenue Generated approximately $633,000 for the year from deployment service jobs alone.
IHP Corporate Service Deployment Pipeline Currently stands at $1,000,000 in open proposals for 2025.
New Product Launches: TOMI launched new and diverse service offerings in February 2024, including the innovative SIS SA product line.
Sales Surge in BIT Solutions: BIT solution sales reached approximately $300,000, marking nearly a 200% increase from just over $100,000 in the first quarter of last year.
SteraMist Pro Certified Program: The company has developed the SteraMist Pro certified program to educate the market on the importance of protective disinfection.
Market Expansion: TOMI is expanding its customer outreach through targeted marketing initiatives and strategic partnerships, including collaborations with PBSC and AlgaFeed.
International Distribution Growth: Two international distributors added SteriMist products to their customer base in Q1.
New Partnerships: TOMI is focused on rebuilding brand presence in Panama, Nigeria, and Israel, while establishing new relationships in Australia and Chile.
Sales Backlog Increase: Sales backlog increased from approximately $877,000 at the end of 2024 to $1,600,000 by the end of Q1 2025.
Operational Efficiency Improvement: Operating loss improved to approximately $754,000 from $1,226,000 in the same quarter last year.
Strategic Partnerships: TOMI is actively seeking strong global partners for 2025 and enhancing sales infrastructure by establishing new distribution channels.
Focus on Food Safety: TOMI is receiving increased interest in food safety applications, indicating a strategic shift towards this market.
Tariff Trade Policy: The company faces potential risks from changing tariff policies, particularly a recent 15% tariff from South Korea that may impact distributor costs. However, there are currently no significant issues with international sales due to tariffs.
Government Budget Cuts: There are concerns regarding government budget cuts and staff reductions, but the CEO believes this will not significantly affect TOMI, as demand for their products in critical testing and studies is expected to increase.
Complexity in Custom Systems: The introduction of new custom systems (CES and SIS) may lead to complexities in negotiations and implementation timelines, making it challenging to provide precise estimates for expected outcomes.
Market Education: The company is focused on educating the market about their products, which is essential for maintaining competitive advantage and addressing customer needs.
Food Safety Market: There is a growing interest in food safety applications for TOMI's products, which could lead to increased demand, but the market is still developing.
Regulatory Challenges: The company is working on gaining regulatory approval for their products, which is critical for expanding their market reach, particularly in the medical device sector.
Sales Growth: In February, TOMI achieved a 42% increase in total sales compared to February 2024, with a 21% increase in April year-over-year. Year-to-date, there has been a 169% surge in BIT solution sales.
New Partnerships: Recent collaborations with partners like PBSC enable customized IHPO closures, chambers, and hatches for customers.
Product Launches: TOMI launched new service offerings in 2024, including the SIS SA and custom engineered systems.
Customer Expansion: New customers include a division of the US Army, a children's hospital, and various research universities.
Sales Backlog: Sales backlog increased from approximately $877,000 at the end of 2024 to $1,600,000 by the end of Q1 2025.
International Expansion: TOMI is focusing on rebuilding brand presence in Panama, Nigeria, and Israel, and establishing new relationships in Australia and Chile.
Revenue Expectations: TOMI anticipates a positive trend in sales throughout 2025, aiming to improve on last year's numbers.
Financial Position: As of 03/31/2025, TOMI has cash and cash equivalents of approximately $674,000 and working capital of $3,800,000.
Sales Projections: The IHP corporate service deployment pipeline currently stands at $1,000,000 in open proposals for 2025.
Future Orders: TOMI is negotiating $2,000,000 among five potential orders for custom engineered systems.
Market Education: The SteraMist Pro certified program aims to educate the market on the importance of protective disinfection.
Shareholder Return Plan: TOMI Environmental Solutions has not announced any specific share buyback program or dividend program during the call.
The earnings call reveals a mixed financial performance with a significant revenue decline and a shift from operating income to loss. While there is optimism in strategic partnerships and market expansion, the Q&A section highlights uncertainties, especially regarding FDA approval impacts and international sales efforts. The lack of specific guidance and vague responses to key questions further dampen sentiment. Despite some positive long-term prospects, immediate financial challenges and unclear management responses suggest a negative short-term market reaction.
Despite positive developments like high solution sales margins and potential opportunities in pharma manufacturing, the earnings call reveals significant challenges. A 66% revenue decline, increased operating losses, and regulatory hurdles dampen optimism. The Q&A highlights deferred CapEx projects and vague management responses, adding uncertainty. While there are growth prospects, the lack of concrete timelines and financial guidance tempers expectations. Overall, the mixed signals suggest a neutral stock price movement.
The earnings call reflects strong financial performance, with a 42% increase in sales and improved margins and losses. However, the lack of a shareholder return plan and vague guidance for 2025 temper the positive sentiment. The Q&A reveals concerns about regulatory and supply chain issues, and management's unclear responses on tariffs and financial goals add uncertainty. Despite the positive revenue growth, the absence of clear guidance and shareholder return plans, along with operational risks, suggest a neutral stock price movement in the short term.
The earnings call reveals a 42% revenue increase and reduced operating losses, indicating improved financial performance. Despite management's lack of clear guidance for 2025, strong growth in product and service revenues, along with a significant sales backlog, suggests positive momentum. The Q&A section highlights increased interest in food safety applications and potential regulatory advancements, which could drive demand. While regulatory challenges and unclear guidance are concerns, the overall sentiment is positive due to strong financial results and growth prospects.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
